Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression-Reference-Cited by-同舟云学术

Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression

Published:2022-02-18 Issue:4 Volume:37 Page:
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Human Psychopharmacology

Author:

Jesus‐Nunes Ana Paula¹²,Leal Gustavo C.¹²,Correia‐Melo Fernanda S.¹²,Vieira Flávia¹²,Mello Rodrigo P.¹²,Caliman‐Fontes Ana Teresa²,Echegaray Mariana V. F.²,Marback Roberta F.²,Guerreiro‐Costa Lívia N. F.¹²,Souza‐Marques Breno¹²,Santos‐Lima Cassio²,Souza Lucca S.²,Bandeira Igor D.¹²,Kapczinski Flavio³,Lacerda Acioly L. T.⁴⁵⁶⁷,Quarantini Lucas C.¹²^ORCID

Affiliation:

1. Programa de Pós‐graduação Em Medicina e Saúde Faculdade de Medicina da Bahia Universidade Federal da Bahia Salvador Brazil

2. Laboratório de Neuropsicofarmacologia Hospital Universitário Professor Edgard Santos Universidade Federal da Bahia Salvador Brazil

3. INCT‐TM and Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton Ontario Canada

4. Laboratório Interdisciplinar de Neurociências Clínicas Universidade Federal de São Paulo São Paulo Brazil

5. Programa de Distúrbios Afetivos Universidade Federal de São Paulo São Paulo Brazil

6. BR Trials – Clinical Research São Paulo Brazil

7. National Institute of Science and Technology in Translational Medicine CNPq/FAPESP/CAPES São Paulo Brazil

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hup.2836

Reference28 articles.

1. Treatment-resistant depression: therapeutic trends, challenges, and future directions

2. The Comparison of Effectiveness of Various Potential Predictors of Response to Treatment With SSRIs in Patients With Depressive Disorder

3. Comparative study of esketamine and racemic ketamine in treatment‐resistant depression: Protocol for a non‐inferiority clinical trial;Correia‐Melo F. S.;Medical Times,2018

4. Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study

5. Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression;Psychiatry Research;2024-10

2. At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data;Journal of Affective Disorders;2024-09

3. The Use of Ketamine for the Treatment of Anhedonia in Depression;CNS Drugs;2024-06-23

4. Examining the role of AI technology in online mental healthcare: opportunities, challenges, and implications, a mixed-methods review;Frontiers in Psychiatry;2024-05-07

5. Predicting non-response to ketamine for depression: An exploratory symptom-level analysis of real-world data among military veterans;Psychiatry Research;2024-05